LINC00682

Across TCGA pan-cancer cohorts, LINC00682 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC00682 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC00682 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00682 expression acts as an unfavorable survival marker, although some lineages such as STAD and GBM show a favorable association.

LIHC, KIRC, and KICH are the cancer types where LINC00682 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.529	0.747	<.001	66	view →
KIRC	DFS	Quartile	II,III,IV	0.292	0.559	.009	57	view →
KICH	OS	Tertile	All	0.872	0.991	.004	42	view →
UCEC	DFS	Tertile	All	0.819	0.910	.007	42	view →
DLBC	OS	Tertile	II,III,IV	0.279	1.000	.003	36	view →
THYM	DFS	Tertile	All	0.135	0.733	<.001	18	view →
CESC	DFS	Tertile	II,III,IV	0.218	0.557	.019	18	view →
COAD	DFS	Tertile	IV	0.229	0.517	.016	9	view →
LGG	OS	Median	All	0.751	0.845	.003	8	view →
UVM	DFS	Tertile	III,IV	0.321	0.747	.038	6	view →
SKCM	OS	Quartile	III,IV	0.187	0.423	.012	6	view →
STAD	DFS	Quartile	IV	0.816	0.247	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC00682–LIHC (OS)

Open the LIHC breakdown →